These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1778600)

  • 1. Mitotane administration: an unusual cause of hypercholesterolemia.
    Vassilopoulou-Sellin R; Samaan NA
    Horm Metab Res; 1991 Dec; 23(12):619-20. PubMed ID: 1778600
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitotane (o,p'-DDD) administration raises the serum level of high density lipoprotein (HDL) in normotriglyceridemia.
    Gebhardt DO; Moolenaar AJ; van Seters AP
    Horm Metab Res; 1993 Apr; 25(4):240-1. PubMed ID: 8514247
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitotane use in inoperable adrenal cortical carcinoma.
    Lubitz JA; Freeman L; Okun R
    JAMA; 1973 Mar; 223(10):1109-12. PubMed ID: 4739370
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenal carcinoma.
    Freeman DA
    Curr Ther Endocrinol Metab; 1997; 6():173-5. PubMed ID: 9174731
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adrenocortical cancer in children].
    Loredo Abdalá A; Martínez Guerra G; Delgado Gallardo S
    Bol Med Hosp Infant Mex; 1981; 38(1):209-11. PubMed ID: 7284069
    [No Abstract]   [Full Text] [Related]  

  • 6. Metastatic adrenal cortical carcinoma. Documented cure with combined chemotherapy.
    Ostuni JA; Roginsky MS
    Arch Intern Med; 1975 Sep; 135(9):1257-8. PubMed ID: 1164127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal cortical carcinoma: a case report.
    Judy JC; Scardino PL
    J Med Assoc Ga; 1973 Nov; 62(11):377-9. PubMed ID: 4128251
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemorrhage into the peritoneum in the course of treatment of adrenocortical carcinoma with o,p'-DDD and 5-fluorouracil].
    Kasperlik-Zaluska A; Migdalska B
    Endokrynol Pol; 1976; 27(1):111-5. PubMed ID: 1253752
    [No Abstract]   [Full Text] [Related]  

  • 9. [Does Op'DDD possess an antimitotic action? Remarks apropos of its use in the treatment of adrenal adenocarcinomas].
    Bricaire H; Luton JP
    Nouv Presse Med; 1977 Nov; 6(39):3650. PubMed ID: 607185
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenal gland: Cancer target of mitotane identified.
    Holmes D
    Nat Rev Endocrinol; 2015 Nov; 11(11):631. PubMed ID: 26370730
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
    Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
    J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of a metastatic hormone-producing adrenal cancer by a combination of mitotane, tegafur and surgical resection.
    Nakamura S; Kuzuya N; Koide Y; Matsumara M; Watanabe Y; Tomizawa H; Murayama Y; Okuda Y; Takuwa Y; Itakura M
    Endocrinol Jpn; 1990 Oct; 37(5):753-62. PubMed ID: 2086205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia.
    Maher VM; Trainer PJ; Scoppola A; Anderson JV; Thompson GR; Besser GM
    Q J Med; 1992 Sep; 84(305):671-9. PubMed ID: 1480741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of an adrenal cortical carcinoma and its neovascular bed following mitotane therapy: a case report.
    Downing V; Eule J; Huseby RA
    Cancer; 1974 Dec; 34(6):1882-7. PubMed ID: 4434322
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of adrenal carcinomas.
    Schteingart DE; Motazedi A; Noonan RA; Thompson NW
    Arch Surg; 1982 Sep; 117(9):1142-6. PubMed ID: 7115060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up.
    Kasperlik-Zaluska AA; Cichocki A
    J Exp Ther Oncol; 2005; 5(2):125-32. PubMed ID: 16471038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS; Farver TB
    J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's disease.
    Trainer PJ; Besser M
    Lancet; 2000 Jan; 355(9197):68. PubMed ID: 10615912
    [No Abstract]   [Full Text] [Related]  

  • 19. Pigmentary retinopathy, macular oedema, and abnormal ERG with mitotane treatment.
    Ng WT; Toohey MG; Mulhall L; Mackey DA
    Br J Ophthalmol; 2003 Apr; 87(4):500-1. PubMed ID: 12642318
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synthetic cortisol antagonists in the treatment of adrenal gland hypercortisolism. Results of 8 years of use].
    Bricaire H; Luton JP
    Therapie; 1974; 29(5):645-58. PubMed ID: 4462221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.